Journal of Dermatitis

Department of Dermatology, NMCH Patna, India

Publications

• Research Article   
  A Randomized Trial to Evaluate the Efficacy and Safety of 1% Pimecrolimus Cream vs. 0.05% Clobetasol Propionate Cream for the Treatment of Childhood Vitiligo
  Author(s): Preeti Sharma*, Amit Kumar, Amit Ranjan, Dhiraj Kumar, Bidisha Roy, Vikas Shankar and Ramawatar Singh
  
  Objective: To assess the safety and efficacy of topical 1% Pimecrolimus cream vs. 0.05% clobetasol propionate cream for the treatment of childhood vitiligo. Place of work: Department of Dermatology, Nalanda Medical College and Hospital, Patna, India. Participants: In twenty-two children with vitiligo, two symmetrical lesions of about the same size and evolution time were selected. They were devoid of any topical or systemic therapy for two months prior to inclusion. Interventions: Treatment of focal vitiligo with either topical 1% Pimecrolimus cream or 0.05% clobetasol propionate cream for a 3 month period. Main outcome measures: The grade of repigmentation was evaluated by photographs at baseline and again at every 2 week visit. Characteristics of pigment, time.. View more»
  

  Abstract HTML PDF